Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Best Inc. buy krebskrebs

Start price
€8.25
18.10.21 / 50%
Target price
€15.00
18.10.22
Performance (%)
-92.00%
End price
€0.66
19.10.22
Summary
This prediction ended on 19.10.22 with a price of €0.66. The BUY prediction by krebskrebs for Best Inc. performed very badly with a performance of -92.00%. krebskrebs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Best Inc. - - -
iShares Core DAX® 2.594% -1.861% 13.242%
iShares Nasdaq 100 3.553% -2.064% 38.293%
iShares Nikkei 225® 0.687% -8.704% 17.510%
iShares S&P 500 2.209% -1.988% 27.632%

Comments by krebskrebs for this prediction

In the thread Best Inc. diskutieren
Prediction Buy
Perf. (%) -92.00%
Target price 3.000
Change
Ends at

Buy mit Kursziel 3,0

In the thread Trading Best Inc.
Prediction Buy
Perf. (%) -92.00%
Target price 15.000
Change
Ends at 18.10.22

Die von krebskrebs gewählte maximale Laufzeit wurde überschritten